roflumilast 0.5 MG Oral Tablet [Daliresp]

RxCUI: 1091843
RxNorm name: roflumilast 0.5 MG Oral Tablet [Daliresp]
Display name: roflumilast 0.5 MG Oral Tablet [Daliresp]
Full name: roflumilast 0.5 MG Oral Tablet [Daliresp]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Daliresp	ROFLUMILAST	AstraZeneca Pharmaceuticals LP	c9a1d0a8-581f-4f91-a2b8-f419192d0ebf	2020-03-12	Warnings, Adverse reactions	Exact identifier rxcui: 1091843

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
c9a1d0a8-581f-4f91-a2b8-f419192d0ebf	roflumilast 0.5 MG Oral Tablet [Daliresp]	SBD	15	These highlights do not include all the information needed to use DALIRESP safely and effectively. See full prescribing information for DALIRESP. DALIRESP ® (roflumilast) tablets Initial U.S. Approval: 2011	20200312
c9a1d0a8-581f-4f91-a2b8-f419192d0ebf	Daliresp 500 MCG Oral Tablet	SY	15	These highlights do not include all the information needed to use DALIRESP safely and effectively. See full prescribing information for DALIRESP. DALIRESP ® (roflumilast) tablets Initial U.S. Approval: 2011	20200312
c9a1d0a8-581f-4f91-a2b8-f419192d0ebf	Daliresp 0.5 MG Oral Tablet	SY	15	These highlights do not include all the information needed to use DALIRESP safely and effectively. See full prescribing information for DALIRESP. DALIRESP ® (roflumilast) tablets Initial U.S. Approval: 2011	20200312
c9a1d0a8-581f-4f91-a2b8-f419192d0ebf	Daliresp 500 MCG Oral Tablet	PSN	15	These highlights do not include all the information needed to use DALIRESP safely and effectively. See full prescribing information for DALIRESP. DALIRESP ® (roflumilast) tablets Initial U.S. Approval: 2011	20200312